Therefore, the NLRP3 inflammasome pathway may serve as a valuable prophylactic and therapeutic target for the treatment of renal fibrosis and may also provide a potential target for minimizing the severe clinical complications observed in CKD patients with advanced renal impairment. This evidence concerns the gene NLRP3 and renal fibrosis.